The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S38-S44, December 2009

Impact of Diabetes and Obesity on the Prostate and Urethra: Implications to Improved Bladder Dysfunction Understanding and Treatment

  • George J. Christ

      Affiliations

    • Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, North Carolina
    • Corresponding Author InformationCorrespondence: Cell, Tissue and Organ Physiology Program, Wake Forest Institute for Regenerative Medicine, Wake Forest University Baptist Medical Center, Dean Research Building, Room 442, Medical Center Blvd., Winston-Salem, North Carolina 27157 (telephone: 336-713-7296; FAX: 336-713-7290)
  • ,
  • Wade Bushman

      Affiliations

    • Department of Urology, University of Wisconsin Medical School Madison, Madison, Wisconsin
  • ,
  • Matthew O. Fraser

      Affiliations

    • Division of Urology, Department of Surgery, Duke University Medical Center and Durham Veterans Administration Medical Center, Durham, North Carolina

published online 20 October 2009.

Purpose

Alterations in bladder function are well documented in response to diabetes and obesity. Nonetheless, clinical manifestations of bladder dysfunction are diverse and the efficacy of available therapy is suboptimal. Since the bladder is only 1 component of the lower urinary tract, we explored existing evidence for the potential contribution(s) of other major lower urinary tract structures to diabetes and obesity related bladder dysfunction, namely the prostate and the urethra.

Materials and Methods

We performed a MEDLINE® database search of the relevant literature.

Results

A relatively large literature exists on bladder dysfunction and the urethra. However, when additional search terms were added, such as prostate, diabetes and obesity, there was a dramatic decrease in the number of retrieved citations. These observations are consistent with the vanishingly small available literature on the impact of diabetes on prostatic biology and urethral function, and their potential impact on bladder physiology/dysfunction. The available literature documents significant alterations in prostatic biology and urethral function in the setting of diabetes and/or obesity.

Conclusions

The observed diversity in diabetes and obesity related bladder dysfunction, and the variable efficacy of currently available treatments may be related at least in part to the differential impact of these disease states on the complex integration of bladder function with other structural components of the lower urinary tract, namely the urethra and the prostate. More comprehensive investigations of this system should lead to improved understanding of the mechanistic basis for the observed pathophysiology and identify novel treatment regimens.

Key Words: urethra, prostate, diabetes mellitus, obesity, urinary bladder

Abbreviations and Acronyms: BPH, benign prostatic hyperplasia, DM, diabetes mellitus, EUS, external urethral sphincter, LUT, lower urinary tract, LUTS, LUT symptoms, NO, nitric oxide, USM-C, urethral circular smooth muscle, USM-L, urethral longitudinal smooth muscle

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial interest and/or other relationship with Ion Channel Innovations and Terigion.

PII: S0022-5347(09)01833-3

doi:10.1016/j.juro.2009.07.085

The Journal of Urology
Volume 182, Issue 6, Supplement , Pages S38-S44, December 2009